pharmaceutical
Ebola threat intensifies in DR Congo
May 18, 2018Medical Communications Ebola, MSD, biotech, drugs, pharma, pharmaceutical
The Ebola outbreak in the Democratic Republic of Congo is becoming increasingly serious, after it was confirmed that there was …
Amgen/Novartis potential blockbuster migraine med gets FDA nod
May 18, 2018Medical Communications, Sales and Marketing Allergan, Amgen, Novartis, biotech, drugs, migraine, pharma, pharmaceutical
The first in a new class of migraine treatments has just received approval from the FDA; Amgen and Novartis’ Aimovig …
Study finds Herceptin use can be halved
May 17, 2018Medical Communications, Research and Development Herceptin, Roche, biosimilars, biotech, drugs, pharma, pharmaceutical
A team of researchers from the University of Cambridge and Warwick Clinical Trials have revealed that Roche’s Herceptin is just …
Ipsen receives European first-line approval for Cabometyx
May 17, 2018Sales and Marketing Cabometyx, biotech, drugs, ipsen, pharma, pharmaceutical
Ipsen has revealed that it has received approval for the use of Cabometyx for first-line use in patients with advanced …
UK MPs call for Brexit priority over pharma industry
May 17, 2018Medical Communications ABPI, UK government, biotech, drugs, pharma, pharmaceutical
A new report published by the Business, Energy and Industrial Strategy Committee has called for the UK government to ensure …
Roche gets NICE approval for advanced bladder cancer
May 17, 2018Sales and Marketing Roche, biotech, drugs, pharma, pharmaceutical, tecentriq
Though trial results for Tecentriq (atezolizumab) may not necessarily be going Roche’s way, after a combination treatment failure, the treatment …
How to treat colds? Target the person, not the virus
May 15, 2018Research and Development biotech, common cold, drugs, pharma, pharmaceutical
Researchers from Imperial College London have discovered how to interfere with one of the building blocks that allows the common …
FDA issues warning letter over potential for poisoning at India plant
May 15, 2018Manufacturing and Production FDA, India, biotech, drugs, pharma, pharmaceutical
The FDA has noted a number of failings at a plant in Gujarat, India, but mostly significantly was the finding …
Smell test targets asymptomatic malaria carriers
May 15, 2018Manufacturing and Production, Research and Development biotech, drugs, malaria, pharma, pharmaceutical
Asymptomatic carriers of malaria may be responsible for the onwards transmission of up to 90% of cases, highlighting the importance …
Emergex secures funds in race to develop universal flu vaccine
May 15, 2018Manufacturing and Production, Sales and Marketing Emergex, Innovate UK, biotech, drugs, influenza vaccine, pharma, pharmaceutical
UK-based biotech, Emergex Vaccines, has received £1 million to push its universal flu vaccine through preclinical tests, in the hope …
Takeda financials show why the Shire deal was needed
May 14, 2018Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical
After posting its financials from 2017 and its guidance for the year to come, it’s clear to see why Takeda …
Pharma unfazed by Trump price-reduction proposals
May 14, 2018Medical Communications, Sales and Marketing PhRMA, President trump, biotech, drugs, pharma, pharmaceutical
President Trump’s speech on Friday afternoon had been long-anticipated, ever since he was elected and then hammered the pharma industry …
Top Ten most popular articles on Pharmafile.com this week
May 11, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, EMA, GSK, J&J, JJ, Novartis, Shire, Takeda, Valeant, biotech, drugs, pharma, pharmaceutical
It’s been a week in which one of the largest pharmaceutical takeovers in history took place and yet it’s not …
AZ’s Fasenra stumbles in P3 for COPD
May 11, 2018Medical Communications, Research and Development AstraZeneca, Fasenra, GSK, Nucala, biotech, drugs, pharma, pharmaceutical
AstraZeneca’s Fasenra arrived later on the scene than GSK rival med, Nucala, and so it needed to quickly rack up …
C4 Therapeutics fills out C-Suite with CEO appointment
May 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing C4 Therapeutics, biotech, drugs, pharma, pharmaceutical
C4 Therapeutics has been slowly expanding since its creation in early 2016 out of the prestigious Dana-Farber Cancer Institute. Andrew …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
